LDLR and glioma: It demonstrates that hnRNPA2B1-dependent regulation of the sterol regulatory element-binding protein 2 (SREBP2) and the low-density lipoprotein receptor (LDLR) contributes to the dysregulation of cholesterol metabolism, thereby promoting the malignant characteristics of glioma cells (116).